Cardea Bio
VerifiedA manufacturer of graphene-based biosensors being used to monitor biological systems using semiconductors.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$26—39m (Dealroom.co estimates Jan 2021.)
San Diego California (HQ)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor | $0.0 | round |
N/A | $0.0 | round | |
investor investor investor | $0.0 | round | |
investor investor investor investor investor investor | $0.0 Valuation: $0.0 | round | |
investor | $0.0 | round | |
investor | $0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |
Related Content
Recent News about Cardea Bio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.